Side-by-Side Comparison · 2026

CagriSema vs Dulaglutide

CagriSema vs Dulaglutide — mechanism, half-life, dosing, and research status compared. Which is right for your protocol?

CagriSema
Metabolic & Mitochondrial

9%) and representing one of the strongest obesity pharmacotherapy results in clinical history. The combination works through complementary mechanisms: GLP-1 suppresses appetite centrally while amylin slows gastric emptying and promotes satiety signaling....

Calculate CagriSema dose →
Dulaglutide
Metabolic & Mitochondrial

Dulaglutide (Trulicity) is a once-weekly GLP-1 receptor agonist approved by the FDA for the treatment of type 2 diabetes and for reducing cardiovascular events in adults with T2DM or cardiovascular risk factors. It is an Fc-fusion protein consisting of two modified GLP-1 molecule...

Calculate Dulaglutide dose →
Key Parameters
Parameter CagriSema Dulaglutide
Category Metabolic & Mitochondrial Metabolic & Mitochondrial
Research Phase III FDA Approved
Half-Life - ~5 days
Typical Dose Cagrilintide 2.4 mg + Semaglutide 2.4 mg 0.75–4.5 mg
Frequency Once weekly Once weekly
Route Subcutaneous (weekly) Subcutaneous (weekly)
FDA Status Not Approved Approved

Calculate doses for both

Use ASCEND's free reconstitution calculator to get exact syringe draw amounts for your vial.

Calculate CagriSema Calculate Dulaglutide
Frequently Asked Questions
What is the difference between CagriSema and Dulaglutide?
CagriSema: 9%) and representing one of the strongest obesity pharmacotherapy results in clinical history. The combination works through complementary mechanisms: GLP-1 suppresses appetite centrally while amylin ... Dulaglutide: Dulaglutide (Trulicity) is a once-weekly GLP-1 receptor agonist approved by the FDA for the treatment of type 2 diabetes and for reducing cardiovascular events in adults with T2DM or cardiovascular ri...
Which has a longer half-life, CagriSema or Dulaglutide?
CagriSema half-life: unknown. Dulaglutide half-life: ~5 days.
Can you stack CagriSema and Dulaglutide?
CagriSema and Dulaglutide are in the same category and used together in research protocols. Always consult relevant literature and follow appropriate guidelines.

For research use only. Not medical advice. ASCEND does not conduct or endorse any specific research protocol. Always consult relevant scientific literature and regulatory guidelines.